Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CatuNeo: Catumaxomab + FLOT in Gastric Cancer with Peritoneal Carcinomatosis
NCT01504256Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Oct 2011
- Primary completion
- Mar 2017
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of catumaxomab in gastric adenocarcinoma, peritoneal carcinomatosis (PC), sponsored by AIO-Studien. Started Oct 2011; status: completed.
02
Drugs
catumaxomab
03
Conditions
gastric adenocarcinomaperitoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT01504256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504256.